Liver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationOrgan TransplantationStem Cell TransplantationTransplantation ConditioningGraft SurvivalGraft RejectionTissue DonorsPancreas TransplantationTransplantationIslets of Langerhans TransplantationTissue and Organ ProcurementTransplantation ImmunologyCell TransplantationTransplantation ChimeraImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicLiving DonorsTreatment OutcomeTransplantation, HeterotopicHeart-Lung TransplantationCord Blood Stem Cell TransplantationTransplantation ToleranceTime FactorsRetrospective StudiesLiver FailurePeripheral Blood Stem Cell TransplantationImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationSkin TransplantationPostoperative ComplicationsWaiting ListsTransplantation, HeterologousRecurrenceMesenchymal Stem Cell TransplantationCorneal TransplantationTissue TransplantationHistocompatibilityTacrolimusCadaverHematologic NeoplasmsCyclosporineWhole-Body IrradiationSurvival AnalysisSurvival RateFollow-Up StudiesDonor SelectionTransplantsLiver DiseasesBrain Tissue TransplantationFacial TransplantationTissue and Organ HarvestingOrgan PreservationBusulfanLiverBrain DeathMultiple Organ FailureKidney Failure, ChronicHLA AntigensMice, Inbred C57BLOrgan SizeLeukemiaRisk FactorsCombined Modality TherapyBronchiolitis ObliteransAntilymphocyte SerumCytomegalovirus InfectionsAcute DiseaseRats, Inbred LewMycophenolic AcidRemission InductionBlood Group IncompatibilityHand TransplantationPostoperative PeriodOrgan SpecificityHematopoietic Stem CellsAnemia, AplasticPrognosisMyeloablative AgonistsEnd Stage Liver DiseaseCyclophosphamideCell DifferentiationNeoplasm TransplantationPatient SelectionKidneyT-LymphocytesProspective StudiesOrgan of CortiDisease-Free SurvivalLiver Failure, AcuteChimerismMelphalan